Congress locks in biomedical research funding, shields it from budget cuts.

What it does

This bill authorizes and appropriates roughly $52–102 billion annually to the National Institutes of Health, $9–19 billion to the CDC, $2–5 billion to the Department of Defense health research program, and $1–2 billion to the VA medical research program, with automatic increases tied to inflation through 2037 and beyond. It exempts these appropriations from budget sequestration (automatic spending cuts) and removes them from congressional pay-as-you-go budget scorecards, ensuring the money flows regardless of deficit rules.

Why we flagged it

The bill's sole operative mechanism is authorizing and appropriating federal funds to four established public-health and medical-research agencies, with inflation protection and sequestration exemption. It is a straightforward appropriations measure, not a regulatory change, tax provision, or private-sector carve-out.

What the text implies

• Sequestration exemption removes these agencies from deficit-reduction pressure, potentially shifting budget cuts to other federal programs if overall spending caps remain in place.
• PAYGO exemption means the bill does not trigger automatic spending offsets elsewhere in the budget, effectively treating biomedical research as exempt from fiscal discipline rules that apply to other spending.
• Automatic CPI adjustment through 2037 and beyond locks in real-dollar growth without future congressional reauthorization, reducing legislative flexibility but ensuring stable long-term funding.

Section numbers refer to the bill text the analysis read — linked under Primary records below.

Who it affects

Ordinary citizens benefit from sustained, inflation-protected federal investment in medical research, disease prevention, and veteran health innovation. The exemption from sequestration ensures these funds are not cut during budget crises, protecting long-term research continuity that produces treatments, vaccines, and public-health advances.

Who stands to gain

• National Institutes of Health (federal agency)
• Centers for Disease Control and Prevention (federal agency)
• Department of Defense health research programs (federal agency)
• Department of Veterans Affairs medical research (federal agency)
• Academic medical centers and research universities (indirect, as NIH grant recipients)
• Pharmaceutical and biotechnology companies (indirect, as research collaborators and drug-development

Named in the bill

National Institutes of Health (NIH), Centers for Disease Control and Prevention (CDC), Department of Health and Human Services (HHS), Department of Defense (DoD), Department of Veterans Affairs (VA), Balanced Budget and Emergency Deficit Control Act of 1985, Statutory Pay-As-You-Go Act of 2010, H. Con. Res. 71 (115th Congress), Bureau of Labor Statistics, Consumer Price Index (CPI)

Where it stands

4 cosponsors: 4 Democrats.

• May 12, 2026 — Introduced · Congress.gov: “Introduced in Senate”
• May 12, 2026 — Referred to Senate Committee on Appropriations · Congress.gov: “Read twice and referred to the Committee on Appropriations. (text: CR S2239)”

Dates and quoted wording are Congress.gov's action record; the timeline shows status changes, not every procedural step.

Money around this bill

5 lobbying clients named this bill on 5 disclosure filings across 1 quarter, Jun 2026 to Jun 2026. Those filings disclosed $2,065,000 in lobbying spend. A filing names 31 bills on average, so that figure is what each filing reported, not a share belonging to this bill.

More lobbying clients named this bill than 78% of bills with at least one filing.

Richard Durbin, the sponsor, reported $-29,800 in PAC receipts in the 2026 cycle.

• American Cancer Society Cancer Action Network Inc — $1,240,000 on 1 filing
• Blood Cancer United (fka the Leukemia & Lymphoma Society) — $590,000 on 1 filing
• American College of Obstetricians and Gynecologists — $96,000 on 1 filing
• Federation of American Societies for Experimental Biology — $89,000 on 1 filing
• University of Illinois — $50,000 on 1 filing

Lobbying Disclosure Act filings through Jul 20, 2026. A filing shows who paid to lobby on a bill it names, not what changed.